Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Clinical Study of Forodesine in Japanese Recurrent/Refractory Peripheral T-cell Lymphoma Patients

NCT01776411 is registered in ClinicalTrials.gov with Mundipharma K.K. as lead sponsor.

NCT NCT01776411
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01776411 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Clinical Study of Forodesine in Japanese Recurrent/Refractory Peripheral T-cell Lymphoma Patients
Lead sponsor
Mundipharma K.K.
Phase
Phase 1/2
Overall status
Completed
Start date
January 31, 2013
Completion date
April 26, 2017
Enrollment
49 (estimated)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent or refractory ptcl